[go: up one dir, main page]

UA116349C2 - Спосіб одержання морфолінпіримідинових похідних піразолу - Google Patents

Спосіб одержання морфолінпіримідинових похідних піразолу

Info

Publication number
UA116349C2
UA116349C2 UAA201413001A UAA201413001A UA116349C2 UA 116349 C2 UA116349 C2 UA 116349C2 UA A201413001 A UAA201413001 A UA A201413001A UA A201413001 A UAA201413001 A UA A201413001A UA 116349 C2 UA116349 C2 UA 116349C2
Authority
UA
Ukraine
Prior art keywords
preparation
triazole compounds
pyrimidino
pyrazolo
triazole
Prior art date
Application number
UAA201413001A
Other languages
English (en)
Inventor
Ханс-Крістіан Мілітцер
Йоганнес Еггерт
Original Assignee
Байєр Фарма Акцієнгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA116349(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байєр Фарма Акцієнгезелльшафт filed Critical Байєр Фарма Акцієнгезелльшафт
Publication of UA116349C2 publication Critical patent/UA116349C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Даний винахід стосується способу одержання 1-[6-(морфолін-4-іл)піримідин-4-іл]-4-(1Н-1,2,3-триазол-1-іл)-1Н-піразол-5-олу (І - енольна форма) або 2-[6-(морфолін-4-іл)піримідин-4-іл]-4-(1Н-1,2,3-триазол-1-іл)-1,2-дигідро-3Н-піразол-3-ону (І - кето-форма) і натрій-1-[6-(морфолін-4-іл)піримідин-4-іл]-4-(1Н-1,2,3-триазол-1-іл)-1Н-піразол-5-олату (II), виходячи з 1,2,3-триазолу (Ш), метилового ефіру бромоцтової кислоти (IV-Me-Br) або етилового ефіру бромоцтової кислоти (IV-Et-Br), 4,6-дихлорпіримідину (VIII), морфоліну (IX) і гідразину (XII).
UAA201413001A 2012-05-08 2013-05-06 Спосіб одержання морфолінпіримідинових похідних піразолу UA116349C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12167152 2012-05-08
PCT/EP2013/059418 WO2013167552A1 (de) 2012-05-08 2013-05-06 Verfahren zur herstellung von triazol-verbindungen

Publications (1)

Publication Number Publication Date
UA116349C2 true UA116349C2 (uk) 2018-03-12

Family

ID=48325714

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201413001A UA116349C2 (uk) 2012-05-08 2013-05-06 Спосіб одержання морфолінпіримідинових похідних піразолу

Country Status (35)

Country Link
US (1) US10301289B2 (uk)
EP (1) EP2847183B1 (uk)
JP (1) JP6149104B2 (uk)
KR (1) KR102086389B1 (uk)
CN (1) CN104411704B (uk)
AP (1) AP2014008089A0 (uk)
AU (1) AU2013258107B2 (uk)
BR (1) BR112014027564B1 (uk)
CA (1) CA2872726C (uk)
CL (2) CL2014003003A1 (uk)
CO (1) CO7121324A2 (uk)
CR (1) CR20140514A (uk)
CU (1) CU20140128A7 (uk)
DK (1) DK2847183T3 (uk)
DO (1) DOP2014000254A (uk)
EA (1) EA027804B1 (uk)
ES (1) ES2641205T3 (uk)
HR (1) HRP20171321T1 (uk)
HU (1) HUE034430T2 (uk)
IL (1) IL235441A (uk)
LT (1) LT2847183T (uk)
MX (1) MX350519B (uk)
MY (1) MY184577A (uk)
NZ (1) NZ701661A (uk)
PE (1) PE20142453A1 (uk)
PH (1) PH12014502482A1 (uk)
PL (1) PL2847183T3 (uk)
PT (1) PT2847183T (uk)
RS (1) RS56255B1 (uk)
SG (2) SG10201609319YA (uk)
SI (1) SI2847183T1 (uk)
TN (1) TN2014000469A1 (uk)
UA (1) UA116349C2 (uk)
WO (1) WO2013167552A1 (uk)
ZA (1) ZA201408571B (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2639716B2 (ja) 1988-12-14 1997-08-13 横浜ゴム株式会社 タイヤ成形装置に於けるグリーンタイヤの搬送装置
UY37222A (es) * 2016-05-03 2017-11-30 Bayer Pharma AG PROCEDIMIENTO PARA LA PREPARACIÓN DE DERIVADOS DE 1-FENILO-1,2,4-TRIAZOL SUSTITUIDOS POR 5-HIdroxIalQUILO
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
JP7710897B2 (ja) * 2021-06-01 2025-07-22 三菱ガス化学ネクスト株式会社 １－アルキル－５－ヒドロキシピラゾールの製造方法
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
AR042052A1 (es) 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
AU2004287849A1 (en) * 2003-10-30 2005-05-19 Merck Sharp & Dohme Corp. Aralkyl amines as cannabinoid receptor modulators
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
EP1877399A1 (en) 2005-04-26 2008-01-16 Pfizer Limited Triazole derivatives as vasopressin antagonists
WO2006123242A1 (en) 2005-05-18 2006-11-23 Pfizer Limited 1, 2, 4 -triazole derivatives as vasopressin antagonists
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Also Published As

Publication number Publication date
DOP2014000254A (es) 2016-01-31
ES2641205T3 (es) 2017-11-08
KR102086389B1 (ko) 2020-03-09
AU2013258107B2 (en) 2017-06-22
SG11201407043PA (en) 2014-12-30
CL2014003003A1 (es) 2015-02-13
SI2847183T1 (sl) 2017-10-30
JP2015516403A (ja) 2015-06-11
BR112014027564B1 (pt) 2022-05-03
CU20140128A7 (es) 2015-03-30
AU2013258107A1 (en) 2014-11-27
AP2014008089A0 (en) 2014-11-30
CN104411704B (zh) 2017-12-22
DK2847183T3 (en) 2017-10-02
WO2013167552A1 (de) 2013-11-14
MX2014013448A (es) 2014-12-08
PH12014502482A1 (en) 2015-01-12
RS56255B1 (sr) 2017-11-30
EP2847183A1 (de) 2015-03-18
KR20150018534A (ko) 2015-02-23
JP6149104B2 (ja) 2017-06-14
CR20140514A (es) 2014-12-02
PT2847183T (pt) 2017-10-02
HK1208027A1 (en) 2016-02-19
CL2016001165A1 (es) 2016-12-02
EA201492032A1 (ru) 2015-04-30
EP2847183B1 (de) 2017-06-21
PE20142453A1 (es) 2015-01-17
CO7121324A2 (es) 2014-11-20
EA027804B1 (ru) 2017-09-29
PL2847183T3 (pl) 2017-11-30
HUE034430T2 (en) 2018-02-28
CA2872726C (en) 2020-07-07
CN104411704A (zh) 2015-03-11
TN2014000469A1 (en) 2016-03-30
CA2872726A1 (en) 2013-11-14
US10301289B2 (en) 2019-05-28
NZ701661A (en) 2016-08-26
HRP20171321T1 (hr) 2017-10-20
BR112014027564A2 (uk) 2017-08-22
ZA201408571B (en) 2016-03-30
SG10201609319YA (en) 2016-12-29
MY184577A (en) 2021-04-06
IL235441A (en) 2017-09-28
LT2847183T (lt) 2017-09-25
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
TN2014000469A1 (en) Method for the preparation of triazole compounds
MX2015008927A (es) Proceso para la preparacion de oxiranos y triazoles sustituidos.
GEP20156262B (en) Fungicidal pyrazoles and their mixtures
JO3062B1 (ar) R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
CL2014000125A1 (es) Compuesto fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-etoxi-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; uso de dichos compuestos para combatir hongos fitopatógenos.
MY195782A (en) Carbamoyloxymethyl Triazole Cyclohexyl Acids as LPA Antagonists
EP4286372A3 (en) Pyrimidinones as factor xia inhibitors
WO2011110583A3 (en) Fungicidal mixtures comprising triazole derivatives
UA109775C2 (xx) N-вмісні гетероарильні похідні як інгібітори jak3-кінази
IL229954A0 (en) Fungicidal mutated compounds of 1 – {2 – [2 – halo – 4 – (4 – halogen – phenoxy) – phenyl] – 2 – alkoxy – 2 – cyclyl – ethyl} – 1h [4,2,1]triazole
TN2012000347A1 (en) 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
ME03556B (me) 3-[4-(7h-pirolo[2,3-d]pirimidin-4-il)-1 h-pirazol-1-il]oktan- ili нертan - niтril kао јак inhibiтori
MX377401B (es) Composiciones que comprenden un compuesto de triazol.
WO2014008295A8 (en) Manufacture of 2- (5- bromo-4-(4-cyclopropylnaphthalen-1-yl) -4h-1,2,4-triazol-3-ylthio) acetic acid
MX2014001671A (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]- 2-aluiniloxi-etil}-1h[1,2,4]triazol sustituidos.
NZ627113A (en) Substituted pyrimidine compounds and their use as syk inhibitors
NZ610614A (en) Substituted sodium-1h-pyrazole-5-olate
NZ624636A (en) Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
CL2018003107A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
MX2021002132A (es) Metodo para preparar 2-[(3r)-3--metilmofolin--4-il]-4-(1-metil-1h- pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina.
WO2007013096A8 (en) Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole)
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
PH12016500851B1 (en) 4-{4-[(1 e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1 -en-1 -yl]-2-methylbenzyl}-5-(propan-2-yl)-1 h-pyrazol-3-yl beta-d- glucopyranoside acetate
TH152857A (th) วิธีการสำหรับการเตรียมของสารประกอบไตรอาซอล
IL244933A0 (en) Pharmaceutical dosage forms containing sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(3,2,1-1h-triazol-1-yl)-1h-pyrazol-5-olate